...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Debt

narmac, should it be the case that Don and the gang will negotiate a buy-out that would include all common shares not just their share ownership, for either company. 

 

Koo

 

Share
New Message
Please login to post a reply